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I. Executive Summary 
Surveillance Epidemiology and End Results (SEER) data estimates that 207,090 women 
will be diagnosed with and 39,840 women will die of cancer of the breast in 2011.  Cancer can 
be a very intimidating illness and cause a great deal of anxiety. This anxiety can sometimes 
progress into a very serious medical problem.  Interpersonal relationships, such as that between a 
patient and provider can influence health behavior.  Communication functions of patient-
provider communication such as, information exchange, uncertainty management, can improve 
health outcomes both directly and indirectly.  For example, cancer education can help ease 
anxiety by familiarizing the patient with their particular condition. Additionally, cancer 
education classes facilitate support networks for both the diagnosed and those close to them.  
Increasing the patient’s knowledge and showing them they are not alone are both examples of 
proximal outcomes that lead to immediate outcomes to improve patient satisfaction.   The breast 
health education class at Winship Cancer Institute came about in an effort to coordinate breast 
cancer care for all patients. The class prides itself on not telling patients ‘what’ to do but rather 
providing them with the basic facts regarding breast cancer care so that they can be more 
educated on their treatment options. The goal and/or overall mission of The Breast Cancer 
Education (BCE) Class for the Diagnosed Patient and her Significant Others is to reduce anxiety 
by providing breast cancer education and promoting advocacy for breast cancer patients, while 
providing a network of support and increasing enrollment in clinical trials.   The purpose of this 
capstone project is to provide the tools to perform an impact evaluation on the breast cancer 
education class and its effectiveness in improving breast cancer patient health outcomes while 
examining the benefits of patient-provider communication in cancer education. 
5 
 
II. Literature Review 
Breast Cancer in the United States 
Breast cancer is defined by the National Cancer Institute (NCI) as cancer that forms in 
tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands 
that make milk). It occurs in both men and women, although male breast cancer is rare (National 
Cancer Institute, 2009).  
 
The most common type of breast cancer is ductal carcinoma, which begins in the cells of the 
ducts.  Cancer that begins in the lobes or lobules is called lobular carcinoma and is more often 
found in both breasts than are other types of breast cancer. Inflammatory breast cancer is an 
uncommon type of breast cancer in which the breast is warm, red, and swollen (National Cancer 
Institute, 2009). 
The Surveillance, Epidemiology, and End Results (SEER) program of the National 
Cancer Institute works to provide information on cancer statistics in an effort to reduce the 
burden of cancer among the US Population.  It is estimated that 207,090 women will be 
diagnosed with and 39,840 women will die of cancer of the breast in 2011.  The age-adjusted 
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incidence rate was 122.9 per 100,000 women per year. These rates are based on cases diagnosed 
in 2003-2007 from 17 SEER geographic areas (see Table 1).  
 
Table 1.Incidence Rates by Race (SEER Stat Fact Sheets: Breast, 2011) 
 Race/Ethnicity Female 
All Races 122.9 per 100,000 women 
White 126.5 per 100,000 women 
Black 118.3 per 100,000 women 
Asian/Pacific Islander  90.0 per 100,000 women 
American Indian/Alaska Native  76.4 per 100,000 women 
Hispanic  86.0 per 100,000 women 
 
On January 1, 2007, in the United States there were approximately 2,591,855 women alive who 
had a history of cancer of the breast. This includes any person alive on January 1, 2007 who had 
been diagnosed with cancer of the breast at any point prior to January 1, 2007 and includes 
persons with active disease and those who are cured of their disease (SEER 2007). 
 
Breast Cancer Risk Factors 
Some risk factors for breast cancer include the following: Increasing age, personal history 
of breast cancer, family history of breast cancer, history of radiation therapy to the chest.  Risk 
factors associated with reproductive and menstrual history include: Having children at an older 
age, never having children (National Cancer Institute, 2009). Women who began menstruating 
before age 12 are at an increased risk as well as women who went through menopause after age 
55.   Additionally, the chance of getting breast cancer after menopause is higher in women who 
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are overweight or obese (National Cancer Institute, 2009). 
  In the United States, breast cancer is diagnosed more often in white women than in 
African American/black, Hispanic/Latina, Asian/Pacific Islander, or American Indian/Alaska 
Native women (See Figure 1). 
Figure 1. Female breast cancer incidence rates by race and ethnicity 1997 - 2007 
 
Source: www.cdc.gov/cancer/breast/statistics/race.htm 
 Additionally, breast density can also be a risk factor for breast cancer.   Breasts appear 
on a mammogram (breast x-ray) as having areas of dense and fatty (not dense) tissue. Women 
whose mammograms show a larger area of dense tissue than the mammograms of women of the 
same age are at increased risk of breast cancer. Women who are physically inactive throughout 
life as well as those who drink alcohol may have an increased risk of breast as well (National 
Cancer Institute, 2009). 
Detecting and Diagnosing Breast Cancer 
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There are several signs and symptoms that aid in the diagnosis of breast cancer. A lump 
or thickening in or near the breast or in the underarm area may be a sign of breast cancer. Any 
changes in the size or shape of the breast, such as dimpling or puckering of the skin, could also 
be signs of breast cancer. A nipple turned inward into the breast or fluid, other than breast milk, 
from the nipple, especially if it's bloody, are possible signs of breast cancer. Scaly, red, or 
swollen skin on the breast, nipple, or areola (the dark area of skin that is around the nipple) also 
may be symptoms of breast cancer (National Cancer Institute, 2009). Following the presence of 
these signs and symptoms, the following are used to diagnose breast cancer: clinical breast exam, 
mammography, breast MRI, and biopsy. 
 
Clinical Breast Exam 
A clinical breast exam consists of a health care provider checking a patient’s breast for 
any irregularities.  Those receiving a clinical breast exam may be asked to raise their arms over 
their head, let them hang by their sides, or press their hands against their hips. The provider then 
looks for irregularities such as:  differences in size or shape between breasts, rashes or dimpling 
on the skin of the breasts, or any discharge from the nipple (National Cancer Institute, 2009).  
Using the pads of the fingers to feel for lumps, the provider checks the entire breast, underarm, 
and collarbone area. A lump is generally the size of a pea before anyone can feel it. The exam is 
done on one side and then the other. The provider also checks the lymph nodes near the breast to 
see if they are enlarged.  If a lump is found, the health care provider feels its size, shape, and 
texture and checks to see if the lump moves easily. Benign lumps often feel different from 
cancerous ones. Lumps that are soft, smooth, round, and movable are likely to be benign. A hard, 
9 
 
oddly shaped lump that feels firmly attached within the breast is more likely to be cancer, but 
further tests are needed to diagnose the problem (National Cancer Institute, 2009). 
Doctors recommend that women have regular clinical breast exams and mammograms to 
find breast cancer early. Treatment is more likely to work well when breast cancer is detected 
early (National Cancer Institute, 2009). 
Diagnostic Testing 
A mammogram is an x-ray picture of tissues inside the breast. Mammograms can often 
show a breast lump before it can be felt. They can also show a cluster of tiny specks of calcium, 
also called microcalcifications. Lumps or specks can be from cancer, precancerous cells, or other 
conditions. Further tests are needed to find out if abnormal cells are present (National Cancer 
Institute, 2009). 
NCI recommends women get regular screening mammograms to detect breast cancer early, 
before they have symptoms. Women in their 40s and older should have mammograms every 1 or 
2 years. Women who are younger than 40 and have risk factors for breast cancer should ask their 
health care provider whether they should have mammograms and how often to have them. 
If an abnormal area is found during a clinical breast exam or with a mammogram, the doctor 
may order other imaging tests such as ultrasound, MRI, and/or biopsy.  A woman with a lump or 
other breast change may have an ultrasound test. An ultrasound device sends out sound waves 
that people can't hear. The sound waves bounce off breast tissues. A computer uses the echoes to 
create a picture. The picture may show whether a lump is solid, filled with fluid (a cyst), or a 
mixture of both. Cysts usually are not cancer; however a solid lump may be cancer (National 
Cancer Institute, 2009). Magnetic Resonance Imaging (MRI) provides further detail regarding 
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whether cancer may be present.  MRI uses a powerful magnet linked to a computer. It makes 
detailed pictures of breast tissue that can show the difference between normal and diseased tissue 
(National Cancer Institute, 2009). 
 A biopsy is the removal of tissue to look for cancer cells. A biopsy is the only way to tell for 
sure if cancer is present.  If an abnormal area is found a biopsy may be required.  An abnormal 
area may be felt during a clinical breast exam but not seen on a mammogram. An abnormal area 
could also be seen on a mammogram but not be felt during a clinical breast exam. In this case, 
doctors can use imaging procedures (such as a mammogram, an ultrasound, or MRI) to help see 
the area and remove tissue (National Cancer Institute, 2009).  The provider may refer the patient 
to a surgeon or breast disease specialist for a biopsy. The surgeon or doctor will remove fluid or 
tissue from the breast in one of several ways: 
Fine-needle aspiration biopsy: Provider uses a thin needle to remove cells or fluid from a 
breast lump.  
Core biopsy: Provider uses a wide needle to remove a sample of breast tissue.  
Skin biopsy: If there are skin changes on the breast, the provider may take a small sample of 
skin.  
Surgical biopsy: The surgeon removes a sample of tissue. The two types of surgical biopsy 
include incisional biopsy and excisional biopsy. An incisional biopsy takes a part of the 
lump or abnormal area. Likewise, an excisional biopsy takes the entire lump or abnormal 
area. 
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Once the biopsy is performed, a pathologist will check the tissue or fluid removed from the 
breast for cancer cells. If cancer cells are found, the pathologist can tell what kind of cancer it is.  
Early detection has been shown to play a significant role in treating breast cancer. Screening 
is important because it allows for early detection.  Chu and colleagues examined trends in breast 
cancer in the United States using the mortality data in SEER.  Chu et al. reported that the age-
adjusted breast cancer mortality rate for U.S. white females dropped 6.8% from 1989 through 
1993. Using piecewise regression Chu et al. observed a significant decrease (P<10^4) in the 
slope of the mortality trend. They reported an approximate 2% decrease in slope per year in 
every decade of age from 40 to 79 years of age. They attributed this decreasing trend to be a 
result of increases in mammography and advancements in treatment options (Chu, et al., 1996). 
Treatment Options 
Different types of treatment are available for patients with breast cancer. Some treatments 
are standard (the currently used treatment), and some are being tested in clinical trials. A 
treatment clinical trial is a research study meant to help improve current treatments or obtain 
information on new treatments for patients with cancer. When clinical trials show that a new 
treatment is better than the standard treatment, the new treatment may become the standard 
treatment. Some clinical trials are open only to patients who have not started treatment (National 
Cancer Institute, 2009).  The different treatment options available include surgery, 
chemotherapy, and radiation. 
Most patients with breast cancer have surgery to remove the cancer from the breast.  
Breast-conserving surgery, for example, includes operations to remove cancer but not the breast 
itself.  Lumpectomy and partial mastectomy both involve removing the cancer and surrounding 
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tissue.   Patients who are treated with breast-conserving surgery may also have some of the 
lymph nodes under the arm removed for biopsy. This procedure is called lymph node dissection. 
It may be done at the same time as the breast-conserving surgery or after. Lymph node dissection 
is done through a separate incision (National Cancer Institute, 2009). 
There are more invasive surgeries to treat for breast cancer such as a total mastectomy, 
modified radical mastectomy, or a radical mastectomy. A total mastectomy is defined as surgery 
to remove the whole breast that has cancer and can sometimes include removal of some lymph 
nodes under the arm for biopsy.  A modified radical mastectomy is defined as removal of the 
whole breast that has cancer, many of the lymph nodes under the arm, the lining over the chest 
muscles, and sometimes part of the chest wall.  A radical mastectomy is defined as surgery to 
remove the breast that has cancer, chest wall muscles under the breast, and all of the lymph 
nodes under the arm (National Cancer Institute, 2009).  
Another treatment option that is available is chemotherapy.  Chemotherapy is a cancer 
treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by 
stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or 
muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body 
(systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an 
organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas 
(regional chemotherapy). The way the chemotherapy is given depends on the type and stage of 
the cancer being treated (National Cancer Institute, 2009). 
Chemotherapy may be given before surgery to remove the tumor. When given before 
surgery, chemotherapy will shrink the tumor and reduce the amount of tissue that needs to be 
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removed during surgery. Treatment given before surgery is called neoadjuvant therapy.  Even if 
the doctor removes all the cancer that can be seen at the time of the surgery, some patients may 
be given radiation therapy, chemotherapy, or hormone therapy after surgery to kill any cancer 
cells that are left.  Furthermore, treatment given after the surgery to lower the risk that the cancer 
will come back is called adjuvant therapy (National Cancer Institute, 2009). 
Hormone replacement therapy (HRT) is another treatment option available to those 
diagnosed with hormone receptive cancer.  There are different drugs available to women 
dependent upon whether they have gone through menopause or not.  For women who have not 
gone through menopause the most common HRT is Tamoxifen.  Tamoxifen is a pill that slows or 
stops the growth of cancer cells that are in the body. This drug can prevent the original breast 
cancer from returning and also helps prevent the development of new cancers in the other breast 
(National Cancer Institute, 2009).   Tamoxifen is taken every day for 5 years.   For those women 
who have gone through menopause an aromatase inhibitor, which prevents the body from 
making a form of estrogen (estradiol), is taken. Examples of aromatase inhibitors 
are anastrazole, exemestane, and letrozole. In some cases Tamoxifen is also given to women who 
are on an aromatase inhibitor but for a shorter period of time. 
Cancer can be a very intimidating illness and cause a great deal of anxiety. This anxiety 
can sometimes progress into a very serious medical problem. The abundance of new terms, 
specialists, and treatment options are often overwhelming and even decrease patient satisfaction 
with care. Additionally, those who are diagnosed with cancer sometimes feel alone and unable to 
relate to those closest to them.  Depression and anxiety associated with early breast cancer was 
examined by Burgess and colleagues (2005) with an observational cohort study done at the NHS 
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breast clinic in London, 170 women provided complete interview data.  The effects of potential 
risk factors were assessed for three periods: around diagnosis (one month before diagnosis to 
four months after diagnosis), medium term (four months to two years after diagnosis), and longer 
term (two years to five years after diagnosis).  The results indicated that nearly 50% of the 
women with early breast cancer had depression, anxiety, or both in the year after diagnosis, 25% 
in the second, third, and fourth years, and 15% in the fifth year.  For the medium term risk 
factors for depression and anxiety were previous psychological treatment, lack of intimate 
confiding relationship, and experience of severe non-cancer difficulties.  In the longer term, 
depression and anxiety were associated with the lack of an intimate confiding relationship, 
younger age, severe non-cancer difficulties, and an earlier episode of depression, anxiety, or both 
after diagnosis (Burgess et al 2005).   
Cancer education, including brochures, pamphlets, and classes can help ease anxiety by 
familiarizing the patient with their particular condition. In addition to making the patient more 
comfortable with their disease, cancer education classes facilitate support networks.  A study 
published by Porochin (1995) examined the effect of preparatory patient education (PPE) on the 
anxiety and satisfaction among 50 subjects drawn from adult patients receiving radical or 
palliative radiation therapy for cancer at a major metropolitan teaching hospital in Western 
Australia. The levels of anxiety and satisfaction between patients receiving the PPE intervention 
with those receiving standard hospital preparation was measured using a quasi-experimental time 
series.  Comparisons of the experimental and control groups were made on 3 occasions: once 
prior to any radiation therapy followed by the first teaching session, secondly during the first 
week of treatment and immediately prior to the second teaching session and thirdly at the 
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completion of the course of radiation therapy.  The results of the multifactorial analysis of 
variance (MANOVA) showed significant main effect of patient education on state anxiety 
F(1,47) – 10.96, p =0.002.  The results indicated that effects were maintained throughout the 
treatment period of up to 7 weeks (Poroch, 1995).  These findings show that the experimental 
group was significantly less anxious than the control group following the first PPE intervention. 
This further supports the importance of patient education on improved health outcomes in patient 
care.  
Today there is a growing awareness regarding the importance of patient education. The 
heightened interest in this area may be the result of several influential factors. First, there has 
been a strong political influence in some countries.   For example, the UK government stated that 
hospitals should offer patients “clear and sensitive explanations of what is happening, on 
practical matters such as where to go and who to see, and on clinical matters, such as the nature 
of an illness and its proposed treatment” (Mills and Sullivan, 2001).  Secondly, there is a belief 
that patients should be much more involved in their own care creating a partnership between 
doctor and patient (especially when dealing with cancer).   In a study done by Hinds et al., a 
convenience sample of 83 patients with cancer were interviewed before and/or after a full course 
of radiotherapy to determine their perceptions about the functions served by the information 
received from general hospital staff.  Patients indicated that they considered information to serve 
three main functions: enabling them to actively participate in their treatment, reducing anxiety, 
and enabling them to prepare and plan for the future (Hinds et al., 1995).  
 In another study in 2001, cancer patients (18 to 75 years old) with moderate pain over 2 
weeks were randomly assigned to the experimental (n = 34) or control group (n = 33).   
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Experimental patients received a 20-minute individualized education and coaching session to 
increase knowledge of pain self-management, to redress personal misconceptions about pain 
treatment, and to rehearse an individually scripted patient-physician dialog about pain control 
(Oliver, Kravitz, Kaplan, & Meyers, 2001). The control group received standardized instruction 
on controlling pain. Data on average pain, functional impairment as a result of pain, pain 
frequency, and pain-related knowledge were collected at enrollment and 2-week follow-up.  At 
baseline, there were no significant differences between experimental and control groups in terms 
of average pain, functional impairment as a result of pain, pain frequency, or pain-related 
knowledge. At follow-up, average pain severity improved significantly more among 
experimental group patients than among control patients (P = .014) (Oliver, Kravitz, Kaplan, & 
Meyers, 2001). The intervention had no statistically significant impact on functional impairment 
as a result of pain, pain frequency, or pain-related knowledge.  In conclusion, compared with 
provision of standard educational materials and counseling, a brief individualized education and 
coaching intervention for outpatients with cancer-related pain was associated with improvement 
in average pain levels. Larger studies are needed to validate these effects and clarify their 
mechanisms (Oliver, Kravitz, Kaplan, & Meyers, 2001). 
In summary, several studies have been done on cancer education and its positive effects 
on patient health outcomes.  Educating those that have been diagnosed with cancer on their 
disease has been shown to significantly reduce anxiety and provide better health outcomes.  
Similar to the interventions discussed in the literature review, the breast cancer education class 
offered at Emory aims to provide the same benefits to its participants.  In the next section of the 
capstone you will find a description of the program along with its goals and objectives.   
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Description of the program 
The breast cancer education (BCE) class meets every 2nd Friday of the month from 9am 
to 1pm in the Family Resource Center at Emory Winship Cancer Institute. Chris McCarthy, NP 
and Mary Brookhart are the primary instructors for the class.  A detailed curriculum of the class 
has been developed and can be found in Appendix B. The class begins with of an overview of 
pathology and common vocabulary associated with breast cancer care.  Subsequently, the class 
participants are given basic information on dietary supplements, exercises, and imaging all 
associated with breast cancer care. Following the overview, PowerPoint presentations are given 
on treatment options including: chemotherapy, radiation, and surgery.   Finally, patients are 
presented with the opportunity to meet and greet with some of the health care professionals they 
could be working with (i.e. lymphadema specialist, nutritionist, social worker, chaplain, breast 
imaging RN, and others).  Upon completion of the class participants are asked to submit a survey 
(see Appendix A) of the course content highlighting their likes and dislikes about the course.  
The BCE class at Winship Cancer Institute came about in an effort to coordinate breast 
cancer care for all patients. Chris McCarthy, a Nurse Practitioner at Winship Cancer Institute, 
started the class about 5 years ago because she believed education was the best way to get those 
involved in the care of breast cancer patients on one accord.  The class prides itself on not telling 
patients ‘what’ to do but rather providing them with the basic facts regarding breast cancer care 
so that they can be more educated on their treatment options.  The specific treatment plans are 
then left for the physician and the patient to determine as a team.  Since the start of the class in 
2005, a few content changes and visual aids have been added to the presentation. However, no 
major changes in program design and/or goals have been made. 
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Purpose of the capstone  
 The purpose of this capstone project is to conduct an evaluation of the BCE class theory 
and provide the steps for an impact evaluation of the class.  An impact evaluation will not be 
conducted; only the steps for future evaluation are presented.   
III. Methods 
Expressing BCE program theory 
 The program theory was initiated from the need to reduce anxiety of patients and their 
family members in an effort to improve health outcomes. To gain understanding about the 
program and to begin to assess the theory, the BCE class was attended and an interview with the 
lead instructor, Chris McCarthy, NP, was conducted. 
A review of the literature regarding breast cancer education and anxiety reduction was 
conducted.  After this review it became evident that a cancer diagnosis instills a great deal of 
anxiety and fear in patients. As a result, patient education was a necessity as part of the program 
model.   This anxiety and fear can be reduced through educating the patient on their condition 
and treatment options.  The breast cancer education class was developed to broaden the patient’s 
knowledge on breast cancer diagnoses and ultimately reduce the associated anxiety.   
Assessing BCE program theory 
To assess the BCE class program theory, the guidelines recommended by Rossi and 
colleagues (2004) were followed and critical assumptions and expectations of the program were 
identified.  The following questions outlined in the Rossi text were answered: Are the program 
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goals and objectives well defined? Are the program goals and objectives feasible? Are the 
procedures for identifying members of the target population, delivering service to them, and 
sustaining that service through completion well defined and sufficient? Are the components, 
activities, and functions of the program well defined and sufficient?  Additionally, the BCE 
theory was assessed by comparing it to the literature review on patient provider communication.   
BCE outcome evaluation 
Given the constraints of the study (e.g., time, IRB), an impact evaluation was not 
conducted.  However, the initial steps that one would consider when planning a study to conduct 
an impact evaluation are outlined.  These steps include: understanding the program’s stage of 
development; developing impact evaluation questions and brief rationale for conducting an 
impact evaluation; identifying the program’s goals and objectives; selecting an evaluation design 
and rationale for that design (including one or more alternatives you considered and their pro’s 
and con’s); selecting a potential target populations; recruitment and selection of study 
participants; and designing measures of the evaluation.   
 
IV. Results 
Part 1: Expressing BCE Theory 
Figure 2 demonstrates possible starting points for identifying theoretical mechanisms that 
might account for ways in which patient – provider communication affects heath outcomes 
(Street Jr. & Epstein, 2007).   For example, the breast cancer education class can directly 
alleviate emotional distress by providing the patient with a clearer understanding of their 
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Proximal Outcomes
•Understanding
•Satisfaction
•Clinician‐patient agreement
•Trust
•Feeling 'known'
•Patient feels involved
•Rapport
Intermediate Outcomes
•Access to care
•Quality medical descision
•Commintment to treatment
•Trust in system
•Social support
•Self‐care skills
•Emotional management
Health outcomes
•Survival
•Cure/remission
•Less suffering
•Emotional well‐being
•Pain control
•Fuctional ability
•Vitality
Communication fuctions
•Information exchange
•Responding to emotions
•Managing uncertainty
•Fostering relationships
•Making decisions
•Enabling self‐management
diagnosis helping to reduce the patient’s anxiety.  This basic framework outlines the breast 
cancer education class and displays the initial steps of the program theory.  A description of the 
program theory and the applicable patient centered communication functions that support the 
breast cancer education class are described later in this capstone.  
Figure 2. Direct and Indirect Pathways from Communication to Health Outcomes 
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Description of Impact Model: A cancer diagnosis is a common cause of anxiety.  Stress from 
being diagnosed with cancer can be induced by a lack of education on the disease and what 
treatment options are available. Additionally, family member’s anxiety and fear can also increase 
stress levels in the newly diagnosed cancer patient.  Those that are newly diagnosed are often 
influenced by prior perceptions of cancer patients and what treatment options they think are 
available without being properly informed.  The breast health education class aims to reduce this 
stress by educating the newly diagnosed patient and their family members on basic terminology, 
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treatment options, and familiarizing them with the overall clinic.  Generally, this reduction in 
stress aims to reduce anxiety levels prior to them becoming a medical issue.  This impact model 
supports the breast cancer education class’s impact theory by highlighting anxiety reduction 
through attendance of the BCE class.  The class also correlates with several themes of patient-
provider communication.  These themes include managing the patient’s uncertainty, information 
exchange, responding to emotions, and making decisions.  “Good communication is often 
associated with improved physical health, more effective chronic disease management, and 
better health-related quality of life long after the encounter” (Street Jr. & Epstein, 2007).     
Description of the BCE Class Curriculum:  
The breast cancer education class is held every second Friday of the month in the 
Winship Cancer Institute Resource Center.  The class is taught by Chris McCarthy, NP and Mary 
Brookhart.  The class is geared toward the newly diagnosed breast cancer patient and their family 
members and is meant to help ease the anxiety associated with a breast cancer diagnosis.  The 
class follows the exact same curriculum each week. The curriculum was developed to provide 
the class instructors with a more concrete description of the sections taught in the course.  The 
breast cancer education class curriculum includes the following: Educating the patients on 
vocabulary associated with breast cancer;  providing reading materials on pathology, dietary 
supplements, exercises, and imaging associated with breast cancer;  giving a PowerPoint 
presentation on treatment options; providing an opportunity for patients to meet with some of the 
health care professionals they may be working with.  A detailed description of this curriculum 
may be found in Appendix B. 
Part II: Results of program theory assessment  
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After a brief interview with Christine McCarthy NP, who is one of the proctors of the 
breast cancer education class, insight into the purpose of the class was provided. The class was 
initially developed as a mechanism to streamline breast cancer patient care from the point of new 
diagnosis through the final treatment and follow up.  Every aspect of the breast cancer education 
class aims to educate the patient on their new diagnosis and reduce any anxiety they may have 
incurred upon receiving their diagnosis.  The aspirations of the class are to familiarize newly 
diagnosed breast cancer patients with oncology related terminology, different stages of breast 
cancer and treatment options, to assist in building a support network of family and peers for the 
patient, and to increase awareness of clinical trials. The program theory was developed to reflect 
these aspects of the class and its overall objective of reducing patient anxiety.   
Logic and plausibility of the BCE class 
Are the program goals and objectives well defined? 
The goals of the BCE class are clearly defined and are as follows: The program goal or 
overall mission of The Breast Cancer Education Class for the Diagnosed Patient and her 
Significant Others is to reduce anxiety by providing breast cancer education and promoting 
advocacy for breast cancer patients while providing a network of support and increasing 
enrollment in clinical trials. 
Are the program goals and objectives feasible?  
This education class aims to reduce anxiety among diagnosed cancer patients at Winship 
Cancer Institute and their families. It aims to ameliorate breast cancer patient anxiety before it 
becomes a clinical concern during the treatment process by providing basic education on breast 
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cancer treatment options. In the long term the education class aims to promote more efficient 
care of breast cancer patients and increase patient satisfaction.  After a review of the literature 
these goals are very feasible.  Cancer education has been shown to reduce anxiety and improve 
patient health outcomes.   
Are the procedures for identifying members of the target population well defined and sufficient? 
The target population is identified through the Nurse Navigators Program.  The Nurse Navigator 
is a patient educator and advocate, care coordinator, system navigator, and community 
ambassador on a mission to improve the cancer experience for the individual affected with a 
diagnosis of cancer by being a support system for the patient and his/her family at a critical time 
– after diagnosis and through treatment – and serving as a gateway to the Winship Cancer 
Institute. The goal of the Nurse Navigator Program is to optimize and improve patient, physician, 
organizational, and community clinical quality, service quality and quality outcomes by 
providing consistent and timely care coordination for the cancer program.  The Nurse Navigators 
educate patients on the importance attending the BCE class and the importance of maintaining 
good patient-provider relationships.  This is a great way to identify members of the target 
population and recruit them to participate in the BCE program. 
 Are the components, activities, and functions of the program well defined and sufficient? 
A detailed curriculum of the BCE program was developed using the guidelines outlined 
by   McKenzie and colleagues (2009) and can be found in Appendix B. 
Comparing BCE Theory to Patient Provider Communication Literature 
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Interpersonal communication is one of the most important sources of social influence, a 
process critical to change in health behavior.   The relationship between physician and patient is 
an example of interpersonal communication.  Good communication is often associated with 
improved physical health, more effective chronic disease management, and better health-related 
quality of life long after the encounter (Street Jr. & Epstein, 2007).  The different types of 
patient-provider interaction can be further understood based on the degree of control between the 
provider and the patient. The four degrees of interaction are paternalistic, mutuality, default, and 
consumerism (Street Jr. & Epstein, 2007).  Paternalistic relationships exist when the provider has 
a great deal more control over the relationship than the patient whereas mutuality is more of an 
even distribution of control.  Default relationships exist when neither provider nor patient take a 
dominant role and can often result in patient dissatisfaction. Consumerism, on the other hand, is 
when the patient has far more control than the provider.  Consumerism can result in the provider 
being much more sensitive to the patient’s goals and needs (Street Jr. & Epstein, 2007).   
Clinician-patient communication can affect health directly or can affect it indirectly through the 
mediating effects of proximal outcomes and intermediate outcomes.   
     The patient provider communication states that “direct or indirect communication 
may improve health through various causal mechanisms or pathways” (Street Jr. & Epstein, 
2007).  These might include improved patient knowledge and clinician-patient agreement on 
diagnosis and treatment, improved therapeutic alliances for coordinating patient care and 
involving the patient in care, helping the patient manage negative emotions more effectively, 
building stronger family/social support, higher-quality medical decisions (for example, informed, 
clinically sound, concordant with patient values, and mutually endorsed), and enhanced patient 
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agency (self-efficacy, empowerment, and enablement) (Street Jr. & Epstein, 2007).  These 
aspects of the patient-provider communication are very parallel to the BCE class offered at 
Emory.    Patient knowledge is improved through an overview of the vocabulary often associated 
with breast cancer. A handout of these terms and their definition is given to the class participants 
for their records.  Class participants are also provided with a support network through the other 
participants in the class and those who instruct the class.  
 Patient-provider communication can affect health both directly and indirectly.  
According to Epstein and Street these effects can be through mediating effects of proximal 
outcomes (such as greater mutual understanding, trust, patient satisfaction, and patient 
involvement in decision making) and intermediate outcomes (such as changes in patient health 
behaviors, self-care skills, adherence to treatment, and better medical decisions).  For example, a 
patient that attends the breast cancer education class will be more knowledgeable and have 
greater understanding about their disease leading them to adhere strongly to their treatment plan 
and improvements in their behavior.  Strong adherence to the recommended treatment plan and 
behavior will allow for improved health outcomes. 
There are several themes of patient-centered communication. Table 2 presents examples 
of theoretical and conceptual models that are pertinent to specific functions of clinician-patient 
communication associated with the BCE class held at Emory.  
Table 2.  Representative Models of Patient-Centered Communication Functions   
Communication Function Theoretical/Conceptual 
Models 
Key Theme 
Information exchange Cognitive model Hypothesizes (1) patient 
understanding of medical 
information enhances 
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memory, (2) memory and 
understanding increase patient 
satisfaction, and (3) 
satisfaction increases 
compliance 
Responding to emotions Model of relational topoi Indentifies four dimensions of 
relational communication that 
focus on emotional 
communication: intimacy, 
affection-hostility, emotional 
arousal, and composure 
Managing uncertainty Uncertainty management Posits that the management of 
uncertainty involves multiple 
options ranging from efforts to 
reduce uncertainty (for 
example, to alleviate anxiety) 
to efforts to maintain or create 
uncertainty (for example, to 
have hope) 
Making decisions A linguistic model of patient 
participating in care (Street, 
2001) 
Posits that patient 
participation in consultations, 
including in decision making, 
is a function of predisposing 
factors (for example, 
motivation, beliefs about 
patient involvement), enabling 
factors (for example 
knowledge, communication 
skill), and provider behavior 
(for example, partnership 
building) 
(Street Jr. & Epstein, 2007) 
The key communication functions that the breast cancer education class focuses on are 
responding to emotions, managing uncertainty, making decisions, and information exchange.  
Each function has specific models and themes that help to explain the relevance of the education 
class and patient-provider communication. “A strong patient-provider relationship can directly 
promote emotional well-being through the patient’s sense of feeling known, cared for, and 
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understood” (Street Jr. & Epstein, 2007). Additionally, a strong patient-provider relationship can 
improve patient health outcomes and satisfaction by encouraging adherence to treatment plans.  
Health literacy is an aspect of information exchange that the breast cancer education class 
aims to improve.  Research has shown patients to be dissatisfied with the information they 
receive from physicians due to their lack of health literacy (Street Jr. & Epstein, 2007).  The 
breast cancer education class curriculum includes a section focused on widely used vocabulary 
associated with oncology and particularly dealing with a breast cancer diagnosis.  The class helps 
patients prepare for the obstacles that come along with a cancer diagnosis so that they may make 
informed decisions about their treatment when meeting with their providers.    
“Uncertainty in illness occurs when a person perceives aspects of the illness, treatment, 
and recovery as inconsistent, random, complex, and unpredictable (Epstein and Street, 2077).  
Managing uncertainty is another aspect of patient-provider communication that helps support the 
BCE class.  Managing uncertainty can be difficult because providing information and social 
support do not always equate to feeling less uncertain.  Uncertainty can lead to emotional 
distress, a loss of sense of control, and lower quality of life for some patients. The breast 
education class manages emotions through increasing participant’s knowledge of their disease 
and developing support networks. 
Part III: BCE Impact Evaluation 
Understanding the program’s stage of development 
Currently the breast cancer education class is in full development and slightly taken for 
granted. Promotion of the program is lacking and consists of flyers placed sparingly around the 
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clinic. Presently, the clinic has implemented a Nurse Navigator Program where patient care is 
navigated from their point of entry into the clinic until they are well established. The nurse 
navigators are currently promoting the breast education class in hopes to increase the number of 
participants.  
 Developing impact evaluation questions and rationale for conducting an impact evaluation 
The specific impact evaluation questions are as follows: 
1.  Does the BCE program reduce anxiety? 
2.  Does the BCE program increase enrollment in clinical trials?  
3.  Does the BCE program help newly diagnosed patients form a support network? 
As stated previously, the literature review provides a great deal of evidence with respect 
to the amount of anxiety that goes along with a cancer diagnosis. Education and patient-provider 
communication has been shown to reduce that level of anxiety.  Also, making sure the patient 
has a support network of family, friends, and health care providers and eases the levels of 
anxiety.  Measuring the amount of anxiety reduction the BCE class provides can increase its 
validity.  Additionally, enrollment in clinical trials is an important aspect of cancer care because 
it allows additional treatment options to be explored. 
Identifying the program’s goals and objectives 
The program goal or overall mission of The Breast Cancer Education Class for the 
Diagnosed Patient and her Significant Others is to reduce anxiety by providing breast cancer 
education and promoting advocacy for breast cancer patients while providing a network of 
support and increasing enrollment in clinical trials. 
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This education class aims to reduce anxiety among diagnosed cancer patients at Winship 
Cancer Institute and their families. It aims to ameliorate breast cancer patient anxiety before it 
becomes a clinical concern during the treatment process by providing basic education on breast 
cancer treatment options. In the long term the education class aims to promote more efficient 
care of breast cancer patients and increase patient satisfaction.   
The specific impact objectives are as follows:  
1.  Reduce anxiety by 80% by completion of the course as measured by the pre and post 
test questionnaire. 
2. Provide a support network to 100% of class participants by completion of the course.  
3.  Increase enrollment in clinical trials by 80% after completion of the course. 
Selecting an evaluation design and rationale  
The ideal evaluation design to measure the education class’s effectiveness at reducing 
anxiety is a pre-test post-test design. A questionnaire will be distributed to the class participants 
prior to them taking the class and then again once the class has been completed.  This will take 
place over a six month period (6 classes total). The evaluation questions that will be analyzed are 
as follows:  
1.  On a scale of 1 – 10(1 being the least aware and 10 being fully aware) how aware of your 
treatment options are you?  
2.  On a scale of 1-10 (1 being least anxious and 10 being most anxious) what would you say 
your level of anxiety is associated with your diagnosis?  
3.  On a scale of 1-10 (1 being least likely and 10 being most likely) what is the likelihood that 
you would participate in a clinical trial?  
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These evaluation questions are very applicable to the education class because each of these 
addresses the main objectives of the class.  Assuring that these questions are answered will 
provide insight into the relevance of the education class and its role in increasing patient 
satisfaction.   In order for a program to be successful it needs to accomplish its stated goals, 
otherwise those goals need to be re-evaluated.   
Selecting a potential target populations 
For the breast health education class the population at risk are those with a family history 
of breast cancer. Additionally, the population at risk could be those with a breast cancer 
diagnosis who do not want any education on treatment options because they are not planning on 
getting any treatment.  The target populations in need are those who have been diagnosed with 
breast cancer and are seeking a solution for their anxiety.  The target populations in demand are 
those with a breast cancer diagnosis who are seeking education on treatment options prior to 
beginning treatment.   
 Recruitment and selection of study participants 
Study participants will consist of those who sign up for the breast cancer education class 
for the newly diagnosed patient and their family members.  The pre-tests and consent forms (see 
appendix A and C) will be administered prior to the breast health education class.  The post-test 
will be administered immediately following the class. There is an estimated 6-9 participants 
expected in each session. Attrition should not be an issue when using this primary study design.   
A nurse navigator program has been recently implemented in Winship to assist in 
increasing patient satisfaction. As a result, the breast health education class will be better 
promoted in an attempt to increase the participation to 12-15 participants per session.  
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 Designing measures of the evaluation 
After attending several of the classes, the questionnaire was developed to assess whether 
anxiety is reduced as a result of the education class.  The questions specifically assess whether 
the class participants experienced any level of relief after the course. 
Patients that participate in the EBC education class will be given a pre and post test to 
determine the class’s effectiveness in reducing anxiety.  Documentation of those individuals that 
have taken the class could be recorded in their Emory Electronic Medical Record (EeMR).  The 
medical oncologist could then evaluate the level of anxiety and the general familiarity with 
cancer terms and treatment options in those who have taken the class versus those who haven’t.  
Once the questionnaire data is collected it will be analyzed using SPSS to perform a t-test for 
dependent means to determine the statistical significance of the education class.  This pre-post 
test design will help to determine the initial state of the patient compared to after they have been 
exposed to the health education class.  Additionally, proving the class to be statistically 
significant could lead to a shared breast health education curriculum across other cancer 
treatment centers.   
An alternative evaluation design would be pretest-post-test design where the pre-test is 
given before the education class and the post-test is given 4 months after the treatment process 
begins.  This approach could allow further insight into the patients overall satisfaction with their 
oncologic care at the Winship Cancer Institute. Giving the patient a chance to digest the material 
they learned in the breast cancer education class and allowing them to utilize that information in 
their care prior to giving them the post-test could give more accurate results on the effectiveness 
of the class.  Unfortunately, waiting 3 to 4 months prior to giving the post-test leaves open the 
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opportunity for attrition.  Patients may no longer be receiving care at Emory for many reasons 
(i.e. transferred to another facility, passed away, or already gone into remission). For those that 
may have transferred to another facility or gone into remission could be mailed a paper copy of 
the post-test, however, there is still a window open for them not to fill out and return the 
questionnaire.  
V. Discussion 
The research conducted for this capstone supports the patient-provider communication 
functions and how they are applicable to the breast cancer education class given at Emory.  
Higher levels of depression, anxiety, or both in the first year after a diagnosis of early breast 
cancer highlight the need for dedicated service provision during this time. Improving patient-
provider relationships can have an incredibly beneficial impact on patient health outcomes.  The 
Emory breast center education class in particular focuses on improving four key communication 
functions: responding to emotions, managing uncertainty, making decisions, and information 
exchange.  These key communication functions are improved by educating the class participants 
on their disease and making them feel as those they can better communicate with their provider 
on what treatment options are available.  Research has shown that patient-provider 
communication does affect patient health outcomes and when dealing with diseases such as 
cancer that can be terminal, it is important to make the patient understand what can and cannot 
be done to improve their condition.   
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Appendix A 
 
 
Breast Cancer Education Class Feedback 
Please take a moment to answer the following questions.  We are always looking for ways to improve! 
1. What is your age? 
Please check one. 
_______18 – 30, _______31 – 40, _______41 – 50,  _______51 – 60,  _______61 – 70,  _______71 – 80,  _______80+ 
2.  How would you describe yourself? 
Please check all that apply. 
______A person affected by breast cancer. 
______A friend/family member of a person affected by breast cancer. 
______A health care professional, please specify _______________________________________________________ 
______Other, please specify ________________________________________________________________________ 
_______________________________________________________________________________________________ 
3.  The group setting supported an adequate learning environment. 
Please check one. 
______Strongly Disagree 
______Disagree 
______Neutral 
______Agree 
______Strongly Agree 
Comments?  _____________________________________________________________________________________ 
________________________________________________________________________________________________ 
4.  On a scale of 1 – 10 how aware of your treatment options are you?  (1 being the least aware, and 10 being fully aware). Please circle 
one. 
1 2 3 4 5 6 7 8 9 10 
 
Comments? _________________________________________________________________________________________ 
___________________________________________________________________________________________________ 
5. On a scale of 1-10 what would you say your level of anxiety is associated with your diagnosis? (1 being the least anxious, 10 being most 
anxious).  Please circle one. 
1 2 3 4 5 6 7 8 9 10 
 
Comments? __________________________________________________________________________________________ 
____________________________________________________________________________________________________ 
 
6. On a scale of 1-10 what is the likelihood that you would participate in a clinical trial? (1 being least likely, 10 being most likely). Please 
circle one. 
1 2 3 4 5 6 7 8 9 10 
 
Comments? __________________________________________________________________________________________ 
____________________________________________________________________________________________________ 
 
7. What did you like about the class? 
____________________________________________________________________________________________________ 
____________________________________________________________________________________________________ 
____________________________________________________________________________________________________ 
8.  What (if anything) would you like to have seen done differently? 
_______________________________________________________________________________________________________ 
_____________________________________________________________________________________________________________________
_______________________________________________________________ 
9.  Would you recommend this class to others, why or why not? 
Please check one. 
______Yes, why?_____________________________________________________________________________________ 
______No, why not?__________________________________________________________________________________ 
Comments? _________________________________________________________________________________________ 
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Appendix B 
Breast Cancer Education Class Lesson Plan 
Title of Program: Breast Cancer Education Class for the Newly Diagnosed 
Length of Lesson: 3 hrs 
Resources and References Content Teaching Method 
 Introduction:  
 
The introduction will consist of a 
welcome to make everyone feel 
as though they are in a friendly 
environment.  It will also include 
a general overview of what the 
class will include. 
 
Body: 
 
1.  Overview of common 
vocabulary associated with breast 
cancer. 
• Familiarize the patient 
with foreign vocabulary 
associated with oncology 
• Help ease anxiety and 
make terms associated 
with oncology less 
complex 
 
2.  Overview of pathology 
associated with breast cancer 
diagnosis. 
• Help improve patient-
provider communication 
by familiarizing patients 
with pathologic 
terminology. 
• Patients may bring in 
pathology reports if they 
desire to discuss one on 
one with the NP. 
 
3. Overview of dietary 
supplements, and exercise 
associated with breast cancer 
diagnosis. 
 
4. Overview of 
 
 
 
 
 
 
 
 
 
 
 
(1 -4 – 2hours)  
Reading materials containing 
common oncology vocabulary, 
and terms associated with 
pathology, dietary supplements, 
exercise, and imaging are handed 
out to the class participants in a 
convenient folder. 
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radiology/imaging associated 
with breast cancer 
 
5. Overview of treatment options: 
Chemotherapy, Radiation, and 
Surgery 
 
6. Meet and Greet with health 
care professionals (ie. 
Lymphadema specialists, 
nutritionist, social worker, 
chaplain, breast imaging RN, 
surgeons, etc…) 
 
Conclusion:  
 
1. Completion of class evaluation 
 
 
 
 
 
(5 – 1hour) 
PowerPoint presentations on 
Chemotherapy, Radiation, and 
Surgery are presented. 
 
(6- 30 minutes ) 
Lunch may be provided 
 
 
 
 
Class participants are asked to 
complete a survey of the course 
content highlighting their likes 
and dislikes about the curriculum 
 
Application of Instructional Design Framework to Breast Cancer Education Class 
Stage Content Covered Method of Presentation 
Gain attention 
 
 
 
 
 
 
 
Present stimulus material 
   Tailor message to knowledge      
and values 
  Demonstrate observable 
effectiveness 
  Make desired behaviors easy to 
understand 
 
 
 
 
 
 
 
 
 
 
• Help ease patient’s 
anxiety with 
introductions. 
• Share the benefits of 
coming to a cancer 
education class 
 
 
• Help participants become 
familiar with terms 
associated with breast 
cancer 
• Overview of pathology 
and breast cancer staging 
• Overview on dietary 
supplements, and 
exercise associated with 
breast cancer diagnosis. 
• Overview of radiology 
• Overview of treatment 
options 
• Discuss Clinical Trials 
 
 
 
 
 
 
 
 
 
• Present common 
vocabulary associated 
with breast cancer 
 
• Allow class participants 
to present their pathology 
report to the health care 
professionals for an 
opinion. 
• Dietician will come and 
speak with participants 
on ways to better their 
diet during 
chemotherapy 
• Present ppt presentation 
on radiology at Emory 
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Provide guidance 
 
 
 
 
 
Elicit performance and Provide 
Feedback 
 
 
 
 
 
Enhance Retention and Transfer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Introduce class 
participants to the health 
care providers they may 
be working with 
 
 
• Allow participants to 
meet and greet with the 
health care providers so 
that they may ask 
questions regarding their 
new diagnosis 
 
• Encourage participants to 
ask questions and remain 
in contact with other 
members in their class 
for support 
 
 
 
• Highlight the different 
locations and what 
participants can expect 
from the different 
radiology exams offered. 
• Present class with PPT 
on treatment options 
available. Discuss 
Surgery, Chemotherapy, 
and Radiation 
• Clinical trials 
representative discusses 
importance of clinical 
trials and its benefits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Participants will 
complete a survey on the 
class  
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Appendix C. 
Consent Form:  
Evaluation of the effect of health education on reducing anxiety in breast cancer patients and their 
family members.  
You are being invited to participate in an evaluation of breast cancer education and anxiety reduction. 
This evaluation is being conducted by MPH candidate Jillian Ogden of Georgia State University.  The 
objective of this evaluation is to determine what effect breast cancer education has on reducing patient 
and family member anxiety.  It is being conducted over a six month period. The survey is being given to 
all breast cancer education class participants. 
There are no known risks if you decide to participate in this evaluation, nor are there any costs for 
participating in the evaluation. The information you provide will help to understand how best to provide 
educational materials in an effort to reduce anxiety. The information collected may not benefit you 
directly, but what I learn from this evaluation should provide general benefits to breast cancer patients, 
their families, and class instructors. 
This survey is anonymous. If you choose to participate, do not write your name on the questionnaire. No 
one will be able to identify you. No one will know whether you participated in this evaluation. Nothing 
you say on the questionnaire will in any way influence your present or future evolvement with Emory 
Healthcare. 
Your participation in this study is voluntary. If you choose to participate, please place your completed 
questionnaire in the bright orange locked box outside the patient and family resource center. 
Questionnaires are collected each afternoon by the student. No one at Emory Healthcare has a key to this 
box. If you prefer, you may mail the survey to: Jillian Ogden, MPH Candidate, Department of Health and 
Human Sciences, Georgia State University, Atlanta, GA  30000. 
If you have any questions or concerns about completing the questionnaire or about being in this study, 
you may contact me at (404) 555‐5555 or at jogden3@student.gsu.edu.  
 
The Georgia State Institutional Review Board has reviewed my request to conduct this project.  If you 
have any concerns about your rights in this study, please contact Joanne Smith of the Georgia State‐IRB 
at 404‐555‐2902 or email jogden3@student.gsu.edu.    
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